Funding
Funding not disclosed
Founders
Product
Problem
Cluster headaches are a debilitating condition characterized by intense, unilateral head pain that can occur multiple times a day and last for several hours. These headaches often disrupt sleep, impair daily functioning, and can lead to psychological comorbidities, significantly impacting the quality of life for those affected. Current treatment options are limited, with a need for better and more specific treatments.
Solution
Nervapax is developing a non-invasive neuromodulation device designed to provide a drug-free solution for individuals suffering from cluster headaches. The device delivers low-frequency electrical pulses via the ear canal to target the vagus nerve, aiming to reduce the frequency and intensity of cluster headache attacks. By offering a non-invasive and drug-free alternative, Nervapax seeks to empower patients to take control of their pain and improve their overall well-being, enabling them to maintain normal sleep patterns and participate fully in daily activities. The therapy is designed to be safe and easy to use at home.
Target Audience
The primary target audience includes individuals suffering from cluster headaches, as well as clinicians seeking non-invasive, drug-free treatment options for their patients.
Features
- Non-invasive vagus nerve stimulation via the ear canal
- Drug-free pain management alternative
- Designed for ease of use at home
- Aims to improve sleep quality and overall quality of life